Principal Investigator
Zelia Correa
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230725
Clinical Trial Summary
(Neo)adjuvant IDE196 (darovasertib) in patients with localized ocular melanoma
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Cutaneous Malignancies
Contact Information
Phone Number
305-243-2647